Source:http://linkedlifedata.com/resource/pubmed/id/10400700
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
29
|
pubmed:dateCreated |
1999-8-19
|
pubmed:abstractText |
Within proteins and peptides, both L-asparaginyl and L-aspartyl residues spontaneously degrade, generating isomerized and racemized aspartyl residues. The enzyme protein L-isoaspartate (D-aspartate) O-methyltransferase (E.C. 2.1.1.77) initiates the conversion of L-isoaspartyl and D-aspartyl residues to normal L-aspartyl residues. This "repair" reaction helps to maintain proper protein conformation by preventing the accumulation of damaged proteins containing abnormal amino acid residues. Pcmt1-/- mice manifest two key phenotypes: a fatal seizure disorder and retarded growth. In this study, we characterized both phenotypes and demonstrated that they are linked. Continuous electroencephalogram monitoring of Pcmt1-/- mice revealed that abnormal cortical activity for approximately 50% of each 24-h period, even in mice that had no visible evidence of convulsions. The fatal seizure disorder in Pcmt1-/- mice can be mitigated but not eliminated by antiepileptic drugs. Interestingly, antiepileptic therapy normalized the growth of Pcmt1-/- mice, suggesting that the growth retardation is due to seizures rather than a global disturbance in growth at the cellular level. Consistent with this concept, the growth rate of Pcmt1-/- fibroblasts was indistinguishable from that of wild-type fibroblasts.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticonvulsants,
http://linkedlifedata.com/resource/pubmed/chemical/Dipeptides,
http://linkedlifedata.com/resource/pubmed/chemical/N-acetyl-1-aspartylglutamic acid,
http://linkedlifedata.com/resource/pubmed/chemical/Protein D-Aspartate-L-Isoaspartate...,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Methyltransferases
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
274
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
20671-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10400700-Animals,
pubmed-meshheading:10400700-Anticonvulsants,
pubmed-meshheading:10400700-Cell Division,
pubmed-meshheading:10400700-Dipeptides,
pubmed-meshheading:10400700-Embryo, Mammalian,
pubmed-meshheading:10400700-Female,
pubmed-meshheading:10400700-Male,
pubmed-meshheading:10400700-Mice,
pubmed-meshheading:10400700-Mice, Knockout,
pubmed-meshheading:10400700-Phenotype,
pubmed-meshheading:10400700-Protein D-Aspartate-L-Isoaspartate Methyltransferase,
pubmed-meshheading:10400700-Protein Methyltransferases,
pubmed-meshheading:10400700-Seizures,
pubmed-meshheading:10400700-Sexual Behavior, Animal,
pubmed-meshheading:10400700-Substrate Specificity
|
pubmed:year |
1999
|
pubmed:articleTitle |
Phenotypic analysis of seizure-prone mice lacking L-isoaspartate (D-aspartate) O-methyltransferase.
|
pubmed:affiliation |
Gladstone Institute of Cardiovascular Disease, San Francisco, California 94141-9100, USA. ekim@gladstone.ucsf.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|